title: Serum creatinine phosphokinase activity in psychiatric patients receiving electroconvulsive therapy.
abstract: Elevation of serum creatine phosphokinase (CPK) has been demonstrated in patients with organic brain pathology. It has been alleged that electroconvulsive therapy (ECT) produces significant brain damage. In a group of patients receiving ECT, the levels remained within normal limits although a small rise in skeletal muscle type CPK was demonstrated following treatment. In no case was any brain type CPK isolated.
mesh_terms: D000328:Adult; D001921:Brain / Q000201:enzymology; D003402:Creatine Kinase / Q000032:analysis / Q000097:blood*; D004565:Electroconvulsive Therapy / Q000009:adverse effects; D005260:Female; D006801:Humans; D007527:Isoenzymes; D008297:Male; D001523:Mental Disorders / Q000201:enzymology* / Q000628:therapy; D008875:Middle Aged
chemical_list: D007527:Isoenzymes; D003402:Creatine Kinase